Glucocorticoids exert context-dependent effects on cells of the joint in vitro

Steroids

Volumn 76, Issue 13, 2011, Pages 1474-1482

  Madsen, Suzi H ^a   Andreassen, Kim V ^a   Christensen, Søren T ^b   Karsdal, Morten A ^a   Sverdrup, Francis M ^c   Bay Jensen, Anne Christine ^a   Henriksen, Kim ^a  

^a NORDIC BIOSCIENCE A S   (Denmark)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

^c SAINT LOUIS UNIVERSITY   (United States)

Author keywords

Chondrocytes; Dexamethasone; Ex vivo model; Osteoblasts; Osteoclasts; Prednisolone

Indexed keywords

BONE MORPHOGENETIC PROTEIN 2; CD14 ANTIGEN; COLLAGEN TYPE 2; DEXAMETHASONE; ONCOSTATIN M; PREDNISOLONE; SOMATOMEDIN C; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ARTICLE; BONE TURNOVER; CARTILAGE; CARTILAGE CELL; CELL ACTIVATION; CELL CULTURE; CELL MATURATION; CELL STIMULATION; CELL VIABILITY; COW; EXPLANT; FEMUR HEAD; HISTOLOGY; HUMAN; HUMAN CELL; IN VITRO STUDY; MONOCYTE; MOUSE; NONHUMAN; OSSIFICATION; OSTEOBLAST; OSTEOCLAST; OSTEOCLASTOGENESIS; OSTEOLYSIS; PROTEIN DEGRADATION; STEROIDOGENESIS;

ANIMALS; ANTIGENS, CD14; BONE REMODELING; CARTILAGE, ARTICULAR; CATTLE; CELL LINE; CELL SURVIVAL; CYTOKINES; DEXAMETHASONE; FEMALE; FEMUR HEAD; GLUCOCORTICOIDS; HUMANS; JOINTS; MICE; ORGAN SPECIFICITY; OSTEOBLASTS; OSTEOCLASTS; PREDNISOLONE;

BOVINAE; MURINAE;

EID: 80053565236     PISSN: 0039128X     EISSN: 18785867     Source Type: Journal    
DOI: 10.1016/j.steroids.2011.07.018     Document Type: Article

References (52)

1. I.L. Engvall, B. Svensson, B. Tengstrand, K. Brismar, and I. Hafstrom Impact of low-dose prednisolone on bone synthesis and resorption in early rheumatoid arthritis: experiences from a two-year randomized study Arthritis Res Ther 10 6 2008 R128
2. C.T. Hepper, J.J. Halvorson, S.T. Duncan, A.J. Gregory, W.R. Dunn, and K.P. Spindler The efficacy and duration of intra-articular corticosteroid injection for knee osteoarthritis: a systematic review of level I studies J Am Acad Orthop Surg 17 10 2009 638 646
3. J.A. DiBattista, J. Martel-Pelletier, T. Antakly, G. Tardif, J.M. Cloutier, and J.P. Pelletier Reduced expression of glucocorticoid receptor levels in human osteoarthritic chondrocytes. Role in the suppression of metalloprotease synthesis J Clin Endocrinol Metab 76 5 1993 1128 1134 (Pubitemid 23155424)
4. D. Chrysis, E.M. Ritzen, and L. Savendahl Growth retardation induced by dexamethasone is associated with increased apoptosis of the growth plate chondrocytes J Endocrinol 176 3 2003 331 337 (Pubitemid 36410417)
5. D. Chrysis, F. Zaman, A.S. Chagin, M. Takigawa, and L. Savendahl Dexamethasone induces apoptosis in proliferative chondrocytes through activation of caspases and suppression of the Akt-phosphatidylinositol 3′-kinase signaling pathway Endocrinology 146 3 2005 1391 1397 (Pubitemid 40289327)
6. T. Sadowski, and J. Steinmeyer Effects of non-steroidal antiinflammatory drugs and dexamethasone on the activity and expression of matrix metalloproteinase-1, matrix metalloproteinase-3 and tissue inhibitor of metalloproteinases-1 by bovine articular chondrocytes Osteoarthritis Cartilage 9 5 2001 407 415 (Pubitemid 32734343)
7. F. Nakazawa, H. Matsuno, K. Yudoh, Y. Watanabe, R. Katayama, and T. Kimura Corticosteroid treatment induces chondrocyte apoptosis in an experimental arthritis model and in chondrocyte cultures Clin Exp Rheumatol 20 6 2002 773 781 (Pubitemid 35446967)
8. D.W. Richardson, and G.R. Dodge Dose-dependent effects of corticosteroids on the expression of matrix-related genes in normal and cytokine-treated articular chondrocytes Inflamm Res 52 1 2003 39 49 (Pubitemid 36228477)
9. E.R. Garvican, A. Vaughan-Thomas, C. Redmond, N. Gabriel, and P.D. Clegg MMP-mediated collagen breakdown induced by activated protein C in equine cartilage is reduced by corticosteroids J Orthop Res 28 3 2010 370 378
10. R. Eastell, D.M. Reid, J. Compston, C. Cooper, I. Fogelman, and R.M. Francis A UK Consensus Group on management of glucocorticoid-induced osteoporosis: an update J Intern Med 244 4 1998 271 292 (Pubitemid 28473991)
11. J.R. Hooyman, L.J. Melton III, A.M. Nelson, W.M. O'Fallon, and B.L. Riggs Fractures after rheumatoid arthritis. A population-based study Arthritis Rheum 27 12 1984 1353 1361 (Pubitemid 15190899)
12. L. Caplan, and K.G. Saag Glucocorticoids and the risk of osteoporosis Expert Opin Drug Saf 8 1 2009 33 47
13. E. Canalis, G. Mazziotti, A. Giustina, and J.P. Bilezikian Glucocorticoid-induced osteoporosis: pathophysiology and therapy Osteoporos Int 18 10 2007 1319 1328 (Pubitemid 47389469)
14. L.C. Hofbauer, U. Zeitz, M. Schoppet, M. Skalicky, C. Schuler, and M. Stolina Prevention of glucocorticoid-induced bone loss in mice by inhibition of RANKL Arthritis Rheum 60 5 2009 1427 1437
15. D. Jia, C.A. O'Brien, S.A. Stewart, S.C. Manolagas, and R.S. Weinstein Glucocorticoids act directly on osteoclasts to increase their life span and reduce bone density Endocrinology 147 12 2006 5592 5599 (Pubitemid 44833476)
16. R.S. Weinstein, J.R. Chen, C.C. Powers, S.A. Stewart, R.D. Landes, and T. Bellido Promotion of osteoclast survival and antagonism of bisphosphonate- induced osteoclast apoptosis by glucocorticoids J Clin Invest 109 8 2002 1041 1048 (Pubitemid 34408579)
17. H.J. Kim, H. Zhao, H. Kitaura, S. Bhattacharyya, J.A. Brewer, and L.J. Muglia Glucocorticoids suppress bone formation via the osteoclast J Clin Invest 116 8 2006 2152 2160 (Pubitemid 44162324)
18. L.C. Hofbauer, F. Gori, B.L. Riggs, D.L. Lacey, C.R. Dunstan, and T.C. Spelsberg Stimulation of osteoprotegerin ligand and inhibition of osteoprotegerin production by glucocorticoids in human osteoblastic lineage cells: potential paracrine mechanisms of glucocorticoid-induced osteoporosis Endocrinology 140 10 1999 4382 4389 (Pubitemid 30666099)
19. S. Sivagurunathan, M.M. Muir, T.C. Brennan, J.P. Seale, and R.S. Mason Influence of glucocorticoids on human osteoclast generation and activity J Bone Miner Res 20 3 2005 390 398 (Pubitemid 40293487)
20. H. Oshina, S. Sotome, T. Yoshii, I. Torigoe, Y. Sugata, and H. Maehara Effects of continuous dexamethasone treatment on differentiation capabilities of bone marrow-derived mesenchymal cells Bone 41 4 2007 575 583 (Pubitemid 47385442)
21. M. Jager, J. Fischer, W. Dohrn, X. Li, D.C. Ayers, and A. Czibere Dexamethasone modulates BMP-2 effects on mesenchymal stem cells in vitro J Orthop Res 26 11 2008 1440 1448
22. B. Espina, M. Liang, R.G. Russell, and P.A. Hulley Regulation of bim in glucocorticoid-mediated osteoblast apoptosis J Cell Physiol 215 2 2008 488 496 (Pubitemid 351468961)
23. W. Mak, X. Shao, C.R. Dunstan, M.J. Seibel, and H. Zhou Biphasic glucocorticoid-dependent regulation of Wnt expression and its inhibitors in mature osteoblastic cells Calcif Tissue Int 85 6 2009 538 545
24. F. Buttgereit, H. Zhou, R. Kalak, T. Gaber, C.M. Spies, and D. Huscher Transgenic disruption of glucocorticoid signaling in mature osteoblasts and osteocytes attenuates K/BxN mouse serum-induced arthritis in vivo Arthritis Rheum 60 7 2009 1998 2007
25. C. Zalavras, S. Shah, M.J. Birnbaum, and B. Frenkel Role of apoptosis in glucocorticoid-induced osteoporosis and osteonecrosis Crit Rev Eukaryot Gene Expr 13 2-4 2003 221 235 (Pubitemid 38009171)
26. M.A. Kerachian, C. Seguin, and E.J. Harvey Glucocorticoids in osteonecrosis of the femoral head: a new understanding of the mechanisms of action J Steroid Biochem Mol Biol 114 3-5 2009 121 128
27. M.A. Karsdal, D.J. Leeming, E.B. Dam, K. Henriksen, P. Alexandersen, and P. Pastoureau Should subchondral bone turnover be targeted when treating osteoarthritis? Osteoarthritis Cartilage 16 6 2008 638 646
28. T.S. Kwan, D. Lajeunesse, J.P. Pelletier, and J. Martel-Pelletier Targeting subchondral bone for treating osteoarthritis: what is the evidence? Best Pract Res Clin Rheumatol 24 1 2010 51 70
29. S.H. Madsen, A.S. Goettrup, G. Thomsen, S.T. Christensen, N. Schultz, and K. Henriksen Characterization of an ex vivo femoral head model assessed by markers of bone and cartilage turnover Cartilage 2 3 2011 265 278
30. M.A. Karsdal, S.H. Madsen, C. Christiansen, K. Henriksen, A.J. Fosang, and B.C. Sondergaard Cartilage degradation is fully reversible in the presence of aggrecanase but not matrix metalloproteinase activity Arthritis Res Ther 10 3 2008 R63
31. + monocytes isolated from peripheral blood J Bone Miner Metab 25 1 2007 36 45 (Pubitemid 46012995)
32. N. Ghosh-Choudhury, J.J. Windle, B.A. Koop, M.A. Harris, D.L. Guerrero, and J.M. Wozney Immortalized murine osteoblasts derived from BMP 2-T-antigen expressing transgenic mice Endocrinology 137 1 1996 331 339 (Pubitemid 26005008)
33. A.K. Olsen, B.C. Sondergaard, I. Byrjalsen, L.B. Tanko, C. Christiansen, and A. Muller Anabolic and catabolic function of chondrocyte ex vivo is reflected by the metabolic processing of type II collagen Osteoarthritis Cartilage 15 3 2007 335 342 (Pubitemid 46238248)
34. M.A. Karsdal, A.V. Neutzsky-Wulff, M.H. Dziegiel, C. Christiansen, and K. Henriksen Osteoclasts secrete non-bone derived signals that induce bone formation Biochem Biophys Res Commun 366 2 2008 483 488 (Pubitemid 50010416)
35. K.B. Jonsson, A. Frost, R. Larsson, S. Ljunghall, and O. Ljunggren A new fluorometric assay for determination of osteoblastic proliferation: effects of glucocorticoids and insulin-like growth factor-I Calcif Tissue Int 60 1 1997 30 36 (Pubitemid 27021328)
36. A.C. Bay-Jensen, Q. Liu, I. Byrjalsen, Y. Li, J. Wang, and C. Pedersen Enzyme-linked immunosorbent assay (ELISAs) for metalloproteinase derived type II collagen neoepitope, CIIM-increased serum CIIM in subjects with severe radiographic osteoarthritis Clin Biochem 44 5-6 2011 423 429
37. E.U. Sumer, B.C. Sondergaard, J.C. Rousseau, P.D. Delmas, A.J. Fosang, and M.A. Karsdal MMP and non-MMP-mediated release of aggrecan and its fragments from articular cartilage: a comparative study of three different aggrecan and glycosaminoglycan assays Osteoarthritis Cartilage 15 2 2007 212 221 (Pubitemid 46132104)
38. K. Henriksen, J. Gram, A.V. Neutzsky-Wulff, V.K. Jensen, M.H. Dziegiel, and J. Bollerslev Characterization of acid flux in osteoclasts from patients harboring a G215R mutation in ClC-7 Biochem Biophys Res Commun 378 4 2009 804 809
39. K.L. Camplejohn, and S.A. Allard Limitations of safranin 'O' staining in proteoglycan-depleted cartilage demonstrated with monoclonal antibodies Histochemistry 89 2 1988 185 188
40. G.S. Habib Systemic effects of intra-articular corticosteroids Clin Rheumatol 28 7 2009 749 756
41. A. Skwara, C.D. Peterlein, C.O. Tibesku, D. Rosenbaum, and S. Fuchs-Winkelmann Changes of gait patterns and muscle activity after intraarticular treatment of patients with osteoarthritis of the knee: a prospective, randomised, doubleblind study Knee 16 6 2009 466 472
42. J.P. Mansell, C. Collins, and A.J. Bailey Bone, not cartilage, should be the major focus in osteoarthritis Nat Clin Pract Rheumatol 3 6 2007 306 307 (Pubitemid 46864879)
43. P.M. van der Kraan, E.L. Vitters, N.S. Postma, J. Verbunt, and W.B. Van den Berg Maintenance of the synthesis of large proteoglycans in anatomically intact murine articular cartilage by steroids and insulin-like growth factor I Ann Rheum Dis 52 10 1993 734 741 (Pubitemid 23317573)
44. S.H. Madsen, E.U. Sumer, A.C. Bay-Jensen, B.C. Sondergaard, P. Qvist, and M.A. Karsdal Aggrecanase- and matrix metalloproteinase-mediated aggrecan degradation is associated with different molecular characteristics of aggrecan and separated in time ex vivo Biomarkers 15 3 2010 266 276
45. A.J. Augustine, and J. Oleksyszyn Glucocorticosteroids inhibit degradation in bovine cartilage explants stimulated with concomitant plasminogen and interleukin-1 alpha Inflamm Res 46 2 1997 60 64 (Pubitemid 27116538)
46. A. Rauch, S. Seitz, U. Baschant, A.F. Schilling, A. Illing, and B. Stride Glucocorticoids suppress bone formation by attenuating osteoblast differentiation via the monomeric glucocorticoid receptor Cell Metab 11 6 2010 517 531
47. R. Kalak, H. Zhou, J. Street, R.E. Day, J.R. Modzelewski, and C.M. Spies Endogenous glucocorticoid signalling in osteoblasts is necessary to maintain normal bone structure in mice Bone 45 1 2009 61 67
48. R.S. Weinstein, R.L. Jilka, M. Almeida, P.K. Roberson, and S.C. Manolagas Intermittent parathyroid hormone administration counteracts the adverse effects of glucocorticoids on osteoblast and osteocyte viability, bone formation, and strength in mice Endocrinology 151 6 2010 2641 2649
49. K. Henriksen, A.V. Neutzsky-Wulff, L.F. Bonewald, and M.A. Karsdal Local communication on and within bone controls bone remodeling Bone 44 6 2009 1026 1033
50. M. Jevon, T. Hirayama, M.A. Brown, J.A. Wass, A. Sabokbar, and S. Ostelere Osteoclast formation from circulating precursors in osteoporosis Scand J Rheumatol 32 2 2003 95 100 (Pubitemid 36428347)
51. A. Takuma, T. Kaneda, T. Sato, S. Ninomiya, M. Kumegawa, and Y. Hakeda Dexamethasone enhances osteoclast formation synergistically with transforming growth factor-beta by stimulating the priming of osteoclast progenitors for differentiation into osteoclasts J Biol Chem 278 45 2003 44667 44674 (Pubitemid 37377223)
52. Soe K, Delaisse JM. Glucocorticoids maintain human osteoclasts in the active mode of their resorption cycle. J Bone Miner Res 2010 [Epub ahead of print]. Ref Type: Generic.